Institute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Eco-Enviroment and Bio-Resource of Three Gorges Area, School of Life Sciences, Southwest University, Chongqing 400700, China.
Biochem Biophys Res Commun. 2011 Jul 15;410(4):780-5. doi: 10.1016/j.bbrc.2011.06.059. Epub 2011 Jun 14.
Mycobacterium marinum is a slow-growing pathogenic mycobacterium. It was first isolated by Aronson in 1926 from fish, fish mycobacteriosis or called fish tuberculosis is the common causative agent of bacterial disease in many species of freshwater and marine fish. M. marinum can infect wild fish, aquaculture and ornamental fish, and it has a close relative of the causative agent of human tuberculosis, Mycobacterium tuberculosis. The recently sequenced genome of M. marinum has been shown to contain several putative GntR regulators. This family named after gluconate regulator has a helix-turn-helix structure. Characterization of transcription regulators and their network is an important step towards the complete understanding of cellular physiology. The regulator of this family shares a similar and conserved N-terminal DNA-binding domain, but has a highly diverse C-terminal effector-binding and oligomerization domain. According to the heterogeneity, we classify the M. marinum GntR family to four subfamilies: FadR, HutC, MocR, and YtrA, and these regulators are encoded by 8, 3, 1 and 1 genes, respectively. Thus this study extends the annotation of M. marinum GntR family proteins, and can help to understand the pathogenic role of this family in M. marinum and facilitate future drug design against this pathogen.
海洋分枝杆菌是一种生长缓慢的致病性分枝杆菌。它于 1926 年由 Aronson 首次从鱼类中分离出来,鱼类分枝杆菌病或称为鱼类结核病是许多淡水和海水鱼类中常见的细菌性疾病的病原体。海洋分枝杆菌可感染野生鱼类、水产养殖和观赏鱼类,并且与人类结核病病原体结核分枝杆菌有密切的亲缘关系。最近对海洋分枝杆菌基因组的测序表明,它含有几个假定的 GntR 调节剂。这个以葡糖酸盐调节剂命名的家族具有螺旋-转角-螺旋结构。转录调节剂及其网络的特征是全面了解细胞生理学的重要步骤。该家族的调节剂共享相似且保守的 N 端 DNA 结合结构域,但具有高度多样化的 C 端效应物结合和寡聚化结构域。根据异质性,我们将海洋分枝杆菌 GntR 家族分为四个亚家族:FadR、HutC、MocR 和 YtrA,这些调节剂分别由 8、3、1 和 1 个基因编码。因此,本研究扩展了海洋分枝杆菌 GntR 家族蛋白的注释,并有助于理解该家族在海洋分枝杆菌中的致病作用,以及促进针对该病原体的未来药物设计。